2022
DOI: 10.1101/2022.07.22.501189
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

In silico-based screening for natural product’s structural analogs as new drugs candidate against leishmaniasis

Abstract: Leishmaniasis is a disease with high mortality rates and approximately 1.5 million new cases each year. Despite the new approaches and advances to fight the disease, there are no effective therapies. Hence, this study aims to in silico screen for natural product's structural analogs as new drugs candidate against leishmaniasis. We applied in silico analysis, such as virtual screening, molecular docking, molecular dynamics simulation, and Molecular Mechanics-Generalized Born Surface Area MM/GBSA estimation aimi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 102 publications
0
1
0
Order By: Relevance
“…Likewise, some countries in Latin America have published their own public NPs databases such as the NuBBE DB from Brazil which contains more than 2000 NPs [28], and BIOFACQUIM from Mexico, which contains a total of 531 molecules [29]. Furthermore, NPs databases had been used as a repository to identify several promising candidates to be considered for further development for the treatment of diseases [30], such as Chagas disease [31,32], Tuberculosis [33], Leishmaniasis [34,35], Schistosomiasis [36], and COVID-19 [37]. The present work introduces the first version of the Peruvian Natural Products Database (PeruNPDB), describing its assembly, curation, and chemoinformatic characterization of molecular diversity and coverage in chemical space.…”
Section: Introductionmentioning
confidence: 99%
“…Likewise, some countries in Latin America have published their own public NPs databases such as the NuBBE DB from Brazil which contains more than 2000 NPs [28], and BIOFACQUIM from Mexico, which contains a total of 531 molecules [29]. Furthermore, NPs databases had been used as a repository to identify several promising candidates to be considered for further development for the treatment of diseases [30], such as Chagas disease [31,32], Tuberculosis [33], Leishmaniasis [34,35], Schistosomiasis [36], and COVID-19 [37]. The present work introduces the first version of the Peruvian Natural Products Database (PeruNPDB), describing its assembly, curation, and chemoinformatic characterization of molecular diversity and coverage in chemical space.…”
Section: Introductionmentioning
confidence: 99%